Concepedia

O-188 Encouraging activity and durable responses demonstrated by the epithelial growth factor receptor-tyrosine kinase inhibitor, Erlotinib (Tarceva TM, OSI774), in patients with advanced bronchioloalveolar (BAC) cell carcinoma

Jyoti D. Patel, Vincent A. Miller, Mark G. Kris, Neelam Shah, Barbara Pizzo, Leslie B. Tyson, Maureen F. Zakowski, Natalie Memoli, Robert T. Heelan, David H. Johnson

Lung Cancer · 2003 · 22 citations · 0 references

DOI

Concepts